[Herpes virus infection in immunosuppressed patients].
Tanaka-Taya
Keiko
K
Infectious Disease Surveillance Center, National Institute of Infectious Diseases.
D000998:Antiviral Agents / Q000008:administration & dosage; D006566:Herpesviridae Infections / Q000150:complications*; D006801:Humans; D016867:Immunocompromised Host; D009894:Opportunistic Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D014180:Transplantation / Q000009:adverse effects
D000998:Antiviral Agents